Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Exubera's ghost

thsloppy,

I was thinking the same thing. No offense to my many friends and colleagues in primary care, but they are generally in the dark with cutting edge technology - until they start hearing about it at conferences or drug-rep dinners etc. Until the drug is actually approved, there just is not a lot of publicity.

Share
New Message
Please login to post a reply